Pyruvate kinase deficiency

2,645views

Pyruvate kinase deficiency

Blood and lymphoreticular system

Traumatic, mechanical, and vascular disorders

Flashcards

Pyruvate kinase deficiency

0 of 5 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 1 complete

A 38-year-old man comes to the clinic complaining of fatigue, jaundice, and shortness of breath. Medical history is noncontributory. Temperature is 37°C (98.6°F), pulse is 84/min, respirations are 16/min, and blood pressure is 130/80 mmHg. Physical examination shows scleral icterus. No hepatosplenomegaly is noted. Laboratory tests are obtained, and the results are shown below.  
 
 Laboratory value  Result  Reference Range 
 Hematologic   
 Hemoglobin  8.3 g/dL  13.5-17.5 g/dL 
 Mean corpuscular volume (MCV)   96 fL  80-100 fL 
 Platelet count  210,000/mm3   150,000-400,000/mm3  
 Leukocyte count  9,500/mm3  4,500-11,000/mm3  
 Reticulocyte count   8.6%  0.5-1.5% 
   
Direct Coombs test is negative. Serum 2,3-bisphosphoglycerate levels are increased. Which of the following is most likely to be found on further evaluation? 

Key Takeaways

Pyruvate kinase deficiency is an inherited disorder caused by a mutation in the gene that codes for the enzyme pyruvate kinase. This enzyme is responsible for catalyzing the breakdown of glucose to form pyruvate. Without functional pyruvate kinase, the body is unable to properly convert glucose into energy, which affects the survival of red blood cells and causes them to break down (hemolysis). Symptoms include anemia, fatigue, splenomegaly, and jaundice. Treatment options include blood transfusions, splenectomy for massive splenomegaly, or allogeneic bone marrow transplantation.